1. Home
  2. TVA vs RXST Comparison

TVA vs RXST Comparison

Compare TVA & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVA
  • RXST
  • Stock Information
  • Founded
  • TVA 2024
  • RXST 1997
  • Country
  • TVA United States
  • RXST United States
  • Employees
  • TVA N/A
  • RXST N/A
  • Industry
  • TVA
  • RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • TVA
  • RXST Health Care
  • Exchange
  • TVA Nasdaq
  • RXST Nasdaq
  • Market Cap
  • TVA 303.9M
  • RXST 307.3M
  • IPO Year
  • TVA 2025
  • RXST 2021
  • Fundamental
  • Price
  • TVA $11.02
  • RXST $8.43
  • Analyst Decision
  • TVA
  • RXST Hold
  • Analyst Count
  • TVA 0
  • RXST 11
  • Target Price
  • TVA N/A
  • RXST $11.80
  • AVG Volume (30 Days)
  • TVA 445.1K
  • RXST 633.5K
  • Earning Date
  • TVA 01-01-0001
  • RXST 11-05-2025
  • Dividend Yield
  • TVA N/A
  • RXST N/A
  • EPS Growth
  • TVA N/A
  • RXST N/A
  • EPS
  • TVA N/A
  • RXST N/A
  • Revenue
  • TVA N/A
  • RXST $147,059,000.00
  • Revenue This Year
  • TVA N/A
  • RXST N/A
  • Revenue Next Year
  • TVA N/A
  • RXST $6.71
  • P/E Ratio
  • TVA N/A
  • RXST N/A
  • Revenue Growth
  • TVA N/A
  • RXST 27.68
  • 52 Week Low
  • TVA $9.98
  • RXST $6.32
  • 52 Week High
  • TVA $12.27
  • RXST $55.57
  • Technical
  • Relative Strength Index (RSI)
  • TVA N/A
  • RXST 47.76
  • Support Level
  • TVA N/A
  • RXST $8.33
  • Resistance Level
  • TVA N/A
  • RXST $8.89
  • Average True Range (ATR)
  • TVA 0.00
  • RXST 0.40
  • MACD
  • TVA 0.00
  • RXST 0.07
  • Stochastic Oscillator
  • TVA 0.00
  • RXST 69.13

About TVA Texas Ventures Acquisition III Corp Class A Ordinary Share

Texas Ventures Acquisition III Corp is a blank check company.

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

Share on Social Networks: